Novo Nordisk just introduced a GLP-1 pill, but the company makes more than just weight-loss drugs.

Pfizer is expected to post fourth-quarter adjusted earnings of 57 cents a share on revenue of $16.85 billion, according to analysts polled by FactSet. That compares with adjusted earnings of 63 cents ...

The Morning Bull - US Market Morning Update Monday, Feb, 2 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 0.7% and Nasdaq 100 futures off just over 1%, ...

Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report this week, following on ...

Analysts expect the New York-based company to report quarterly earnings at 57 cents per share, down from 63 cents per share ...

Dividend investors are likely to find the stock's 6.7% yield attractive. That yield is the result of a 100% dividend payout ratio -- meaning the company devotes all its profit to the payments -- so ...

PFE heads into Q4 earnings with strong oncology and Vyndaqel demand, but IRA headwinds, COVID declines and falling estimates ...

Pfizer may look cheap with a ~7% yield, but tight free cash flow, patent cliffs, and limited growth raise downside risk. Read ...

That said, let's consider three stocks yielding well above 4% that income-oriented investors should consider: Pfizer ( PFE +1 ...

If you like dividend stocks, here's a high yielder, a Dividend King, and a turnaround story to consider as January comes to a ...

Shares of Pfizer Inc. PFE shed 2.42% to $25.86 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.02% to ...

As of Wednesday, January 28, Relay Therapeutics, Inc.’s RLAY share price has dipped by 5.18%, which has investors questioning if this is right time to buy.